Anders Grahnén
Sr. Scientific Advisor
Oncology
PCG Clinical Services
Sweden
Biography
Anders has an MSc (Pharm), PhD, in Biopharmaceutics and is one of Sweden’s most experienced people in the design of clinical trials. He is Associate Professor of Clinical Drug Development Sciences at Uppsala University and has gained profound knowledge from his previous positions, which included adjunct Professor of Clinical Trial Methodology, Uppsala University, and Director of Clinical Pharmacology at the Swedish MPA. During his time as Chief Scientific Officer at Quintiles Nordic Operations, Anders oversaw more than 300 clinical trials. Anders is an instrumental resource to assist clients in the early phases of study design and can help ensure studies are on the right track from the start.
Research Interest
Anders is an instrumental resource to assist clients in the early phases of study design and can help ensure studies are on the right track from the start.